METABOLIC-CLEARANCE RATES OF OXYNTOMODULIN AND GLUCAGON IN THE RAT - CONTRIBUTION OF THE KIDNEY

被引:46
作者
KERVRAN, A [1 ]
DUBRASQUET, M [1 ]
BLACHE, P [1 ]
MARTINEZ, J [1 ]
BATAILLE, D [1 ]
机构
[1] HOP BICHAT,INSERM,U10,F-75877 PARIS 18,FRANCE
关键词
Half-life; Hyperglycemic effect; Nephrectomy; Primed-continuous infusion technique;
D O I
10.1016/0167-0115(90)90194-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The half-life (t 1 2) and metabolic clearance rate (MCR) of exogenous natural porcine oxyntomodulin (porcine OXM) and the synthetic analog of rat oxyntomodulin, [Nle27]-OXM (rat OXM), were compared with that of glucagon in control, sham-operated and acutely nephrectomized rats using the primed-continuous infusion technique. The half-disappearance times for porcine OXM (8.2 ± 0.5 min) and rat OXM (6.4 ± 0.5 min) were 3-fold slower than that of glucagon (1.9 ± 0.1 min). Acute bilateral nephrectomy significantly prolonged the half-disappearance time of rat OXM (8.2 ± 0.7 min) and glucagon (3.6 ± 0.4 min) compared with that of sham-operated animals (6.5 ± 0.8 min and 2.5 ± 0.2 min, respectively). The mean MCRs were similar for porcine and rat OXM (11.3 ± 0.7 and 11.9 ± 0.5 ml · kg-1 · min-1) but were 3 times lower than that measured with glucagon (36 ± 5 ml · kg-1 · min-1). Bilateral nephrectomy reduced the MCR of OXM and glucagon by 38% and 34%, respectively. No significant increase in C-terminal glucagon immunoreactivity was noticed during infusion of either porcine or rat OXM, measured directly in plasma, with a specific C-terminal glucagon antiserum or after HPLC. In the course of the glucagon infusion, blood glucose was increased 2-fold, while the same dose of porcine OXM or of rat OXM induced only a small increase over the values in phosphate buffer-infused rats. 10 times higher doses of rat OXM were necessary to obtain a similar hyperglycemic effect. These results indicate that: (1) the metabolism of OXM is 3-fold slower than that of glucagon, (2) renal clearance contributed close to 35% of the overall metabolic plasma extraction for OXM and glucagon and (3) OXM, although effective at a higher dose, when compared with glucagon, displays a hyperglycemic effect probably through the glucagon receptors. © 1990.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 34 条
[1]   SOLID-PHASE PEPTIDE-SYNTHESIS OF HUMAN(NLE-27)-OXYNTOMODULIN - PRELIMINARY EVALUATION OF ITS BIOLOGICAL-ACTIVITIES [J].
AUDOUSSETPUECH, MP ;
DUFOUR, M ;
KERVRAN, A ;
JARROUSSE, C ;
CASTRO, B ;
BATAILLE, D ;
MARTINEZ, J .
FEBS LETTERS, 1986, 200 (01) :181-185
[2]  
AUMELAS A, 1989, INT J PEPT PROT RES, V34, P268
[3]   GLUCAGON KINETICS IN GROWING-RATS FED DIFFERENT LEVELS OF PROTEIN AND OR ENERGY [J].
BALAGE, M ;
GRIZARD, J .
REPRODUCTION NUTRITION DEVELOPMENT, 1984, 24 (03) :251-263
[4]   OXYNTOMODULIN (GLICENTIN-(33-69)) - PHARMACOKINETICS, BINDING TO LIVER-CELL MEMBRANES, EFFECTS ON ISOLATED PERFUSED PIG PANCREAS, AND SECRETION FROM ISOLATED PERFUSED LOWER SMALL-INTESTINE OF PIGS [J].
BALDISSERA, FGA ;
HOLST, JJ ;
KNUHTSEN, S ;
HILSTED, L ;
NIELSEN, OV .
REGULATORY PEPTIDES, 1988, 21 (1-2) :151-166
[5]   ISOLATION OF GLUCAGON-37 (BIOACTIVE ENTEROGLUCAGON OXYNTOMODULIN) FROM PORCINE JEJUNO-ILEUM - CHARACTERIZATION OF THE PEPTIDE [J].
BATAILLE, D ;
TATEMOTO, K ;
GESPACH, C ;
JORNVALL, H ;
ROSSELIN, G ;
MUTT, V .
FEBS LETTERS, 1982, 146 (01) :79-86
[6]   ISOLATION OF GLUCAGON-37 (BIOACTIVE ENTEROGLUCAGON OXYNTOMODULIN) FROM PORCINE JEJUNO-ILEUM - ISOLATION OF THE PEPTIDE [J].
BATAILLE, D ;
COUDRAY, AM ;
CARLQVIST, M ;
ROSSELIN, G ;
MUTT, V .
FEBS LETTERS, 1982, 146 (01) :73-78
[7]  
BATAILLE D, 1988, ANN NY ACAD SCI, V527, P168
[8]   EXON DUPLICATION AND DIVERGENCE IN THE HUMAN PREPROGLUCAGON GENE [J].
BELL, GI ;
SANCHEZPESCADOR, R ;
LAYBOURN, PJ ;
NAJARIAN, RC .
NATURE, 1983, 304 (5924) :368-371
[9]   THE EFFECT OF OXYNTOMODULIN (GLUCAGON-37) AND GLUCAGON ON EXOCRINE PANCREATIC-SECRETION IN THE CONSCIOUS RAT [J].
BIEDZINSKI, TM ;
BATAILLE, D ;
DEVAUX, MA ;
SARLES, H .
PEPTIDES, 1987, 8 (06) :967-972
[10]   OXYNTOMODULIN AND GLICENTIN - BRAIN-GUT PEPTIDES IN THE RAT [J].
BLACHE, P ;
KERVRAN, A ;
BATAILLE, D .
ENDOCRINOLOGY, 1988, 123 (06) :2782-2787